Brief: Dawnrays Pharmaceutical Says Wu Weixian Has Been Appointed As Chief Executive Officer Of Company
16/02/2022 09:40
Feb 16 (Reuters) - Dawnrays Pharmaceutical (Holdings) Ltd
2348.HK :
* WU WEIXIAN HAS BEEN APPOINTED AS CHIEF EXECUTIVE OFFICER
OF
COMPANY
* CHEN SHAOJUN RESIGNED AS AN EXECUTIVE DIRECTOR AND CHIEF
EXECUTIVE OFFICER
Further company coverage: 2348.HK
Recent news on Dawnrays Pharmaceutical (Holdings)
See all newsBrief: Dawnrays Pharmaceutical Says Suzhou Dawnrays Commits To Invest Up To RMB100 Mln In Partnership
Brief: Dawnrays Pharmaceutical (Holdings) Final Dividend Of Hk$0.048 Per Share
Brief: Dawnrays Pharmaceutical Reports HY Net Income Attributable Of RMB104.6 MLN
Brief: Dawnrays Pharmaceutical (Holdings) Posts FY Profit Attributable Of Rmb564.9 Million
Brief: Dawnrays Pharmaceutical (Holdings) Appoints Yu Liwei To Act As CEO